Please join us to celebrate the research accomplishments of the Mazzone Awards Program and to enjoy presentations on ground-breaking research by world-renown Prostate cancer researchers. The A. David Mazzone Research Awards Program funded a series of collaborative and innovative cancer research, career development, community outreach, and training projects to address a range of needs in prostate cancer and Lupron-treatable diseases. This $12 million funding program is a grant from the U.S. District Court for the District of Massachusetts from a pool of unclaimed funds from the 2004 class action suit settlement by TAP Pharmaceuticals. The class action suit was related to marketing and sales practices for the prostate cancer drug Lupron. The Program is administered jointly through DF/HCC and the Prostate Cancer Foundation, and was named in memory of the Honorable Judge A. David Mazzone (June 3, 1928 – October 25, 2004).